APA (7th ed.) Citation

RS, A., E, R., A, T., & G, F. (2019). CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine. Frontiers in immunology, 10, 1806. https://doi.org/10.3389/fimmu.2019.01806

Chicago Style (17th ed.) Citation

RS, Accolla, Ramia E, Tedeschi A, and Forlani G. "CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine." Frontiers in Immunology 10 (2019): 1806. https://doi.org/10.3389/fimmu.2019.01806.

MLA (9th ed.) Citation

RS, Accolla, et al. "CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine." Frontiers in Immunology, vol. 10, 2019, p. 1806, https://doi.org/10.3389/fimmu.2019.01806.